REM-话题@MedSci

#REM#

111篇内容 | 2798人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1752223, encodeId=7b441e52223db, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=热门止痛药Remoxy被FDA连拒3次，拿高薪的CEO说不会放弃, objectType=article, longId=79384, objectId=096fe9384b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=096fe9384b7, replyNumber=0, likeNumber=61, createdTime=2017-08-17, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=096fe9384b7, moduleTitle=热门止痛药Remoxy被FDA连拒3次，拿高薪的CEO说不会放弃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=096fe9384b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752221, encodeId=a3731e5222192, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=9.21 | Remember me！关于老年性痴呆，你了解多少？, objectType=article, longId=78129, objectId=bfc1e81295a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfc1e81295a, replyNumber=0, likeNumber=66, createdTime=2016-10-12, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfc1e81295a, moduleTitle=9.21 | Remember me！关于老年性痴呆，你了解多少？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfc1e81295a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752219, encodeId=2b521e52219ef, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=JAMA Surgery：DiaRem得分可以预测减肥术后糖尿病是否能缓解, objectType=article, longId=67040, objectId=59796e040d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59796e040d5, replyNumber=0, likeNumber=63, createdTime=2016-07-24, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59796e040d5, moduleTitle=JAMA Surgery：DiaRem得分可以预测减肥术后糖尿病是否能缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59796e040d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752220, encodeId=7bbc1e52220e9, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=FDA受理默沙东Remicade（类克）生物仿制药上市申请, objectType=article, longId=69255, objectId=ba9b69255bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba9b69255bf, replyNumber=0, likeNumber=75, createdTime=2016-06-21, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba9b69255bf, moduleTitle=FDA受理默沙东Remicade（类克）生物仿制药上市申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba9b69255bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752218, encodeId=2fec1e52218ed, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=利用PubReMiner汇总分析PubMed查询结果提高查询效率, objectType=article, longId=58302, objectId=4cbd5830243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cbd5830243, replyNumber=0, likeNumber=68, createdTime=2016-07-31, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cbd5830243, moduleTitle=利用PubReMiner汇总分析PubMed查询结果提高查询效率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cbd5830243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752217, encodeId=92821e5221785, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=Hepatology：替诺福韦酯能降低乙肝孕妈妈后代乙肝传染(PreMIT研究）, objectType=article, longId=49257, objectId=d6024925ef8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6024925ef8, replyNumber=0, likeNumber=65, createdTime=2015-12-15, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6024925ef8, moduleTitle=Hepatology：替诺福韦酯能降低乙肝孕妈妈后代乙肝传染(PreMIT研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6024925ef8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752216, encodeId=11ab1e52216ca, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=矿生物仿制药：Epirus联合兰伯西在印度推出Remicade生物仿制药, objectType=article, longId=43632, objectId=55054363267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55054363267, replyNumber=0, likeNumber=69, createdTime=2015-11-09, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55054363267, moduleTitle=矿生物仿制药：Epirus联合兰伯西在印度推出Remicade生物仿制药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55054363267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752215, encodeId=96361e52215d0, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=Celgene新药apremilast临床三期研究失败, objectType=article, longId=37785, objectId=499c3e78532, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=499c3e78532, replyNumber=0, likeNumber=66, createdTime=2014-08-09, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=499c3e78532, moduleTitle=Celgene新药apremilast临床三期研究失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=499c3e78532)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752214, encodeId=62f81e522143d, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=辉瑞计划继续推进Remoxy临床开发, objectType=article, longId=25762, objectId=c3a725e62db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3a725e62db, replyNumber=0, likeNumber=71, createdTime=2014-04-15, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3a725e62db, moduleTitle=辉瑞计划继续推进Remoxy临床开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3a725e62db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752213, encodeId=b7d61e52213b5, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=Cancer Res：靶向炎症促发因子TREM-1预防治疗癌症, objectType=article, longId=9300, objectId=bd649300cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd649300cb, replyNumber=0, likeNumber=103, createdTime=2013-07-14, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd649300cb, moduleTitle=Cancer Res：靶向炎症促发因子TREM-1预防治疗癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd649300cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1752212, encodeId=8f441e5221247, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, objectTitle=Measurement of disease activity in ulcerative colitis: Interobserver agreement a, objectType=article, longId=2737, objectId=64b12e37e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64b12e37e4, replyNumber=0, likeNumber=68, createdTime=2011-11-26, rootId=0, userName=tongyongming, userId=78bc36479935, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64b12e37e4, moduleTitle=Measurement of disease activity in ulcerative colitis: Interobserver agreement a, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64b12e37e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

REM

2020-05-29

tongyongming (审核中...)

前往app查看评论内容

#REM#

热门止痛药Remoxy被FDA连拒3次，拿高薪的CEO说不会放弃

2017-08-17

tongyongming (审核中...)

前往app查看评论内容

#REM#

9.21 | Remember me！关于老年性痴呆，你了解多少？

2016-10-12

tongyongming (审核中...)

前往app查看评论内容

#REM#

JAMA Surgery：DiaRem得分可以预测减肥术后糖尿病是否能缓解

2016-07-24

tongyongming (审核中...)

前往app查看评论内容

#REM#

FDA受理默沙东Remicade（类克）生物仿制药上市申请

2016-06-21

tongyongming (审核中...)

前往app查看评论内容

#REM#

利用PubReMiner汇总分析PubMed查询结果提高查询效率

2016-07-31

tongyongming (审核中...)

前往app查看评论内容

#REM#

Hepatology：替诺福韦酯能降低乙肝孕妈妈后代乙肝传染(PreMIT研究）

2015-12-15

tongyongming (审核中...)

前往app查看评论内容

#REM#

矿生物仿制药：Epirus联合兰伯西在印度推出Remicade生物仿制药

2015-11-09

tongyongming (审核中...)

前往app查看评论内容

#REM#

Celgene新药apremilast临床三期研究失败

2014-08-09

tongyongming (审核中...)

前往app查看评论内容

#REM#

辉瑞计划继续推进Remoxy临床开发

2014-04-15

tongyongming (审核中...)

前往app查看评论内容

#REM#

Cancer Res：靶向炎症促发因子TREM-1预防治疗癌症

2013-07-14

tongyongming (审核中...)

前往app查看评论内容

#REM#

Measurement of disease activity in ulcerative colitis: Interobserver agreement a

2011-11-26

科室
- - 订阅+
  - 更多科室
工具
服务